Novel Treatment Offers Insomnia Sufferers Hope of Quality Sleep
COPENHAGEN, May 13 /PRNewswire/ --
- Circadin(R) Improves Quality of Sleep and Morning Alertness
A new, first in class sleep medication is launched today, offering hope for thousands of sufferers of insomnia in Europe. Circadin(R), sustained-release melatonin, provides natural sleep by increasing the body's own level of this naturally occurring hormone throughout the night. (1)
Melatonin is the hormone responsible for regulating the circadian rhythm (or sleep cycle) and enabling restorative sleep. Circadin(R), the first melatonin agent approved by the European Medicines Agency (EMEA), is now…